AU4685799A – Telomerase inhibitors
– Google Patents
AU4685799A – Telomerase inhibitors
– Google Patents
Telomerase inhibitors
Info
Publication number
AU4685799A
AU4685799A
AU46857/99A
AU4685799A
AU4685799A
AU 4685799 A
AU4685799 A
AU 4685799A
AU 46857/99 A
AU46857/99 A
AU 46857/99A
AU 4685799 A
AU4685799 A
AU 4685799A
AU 4685799 A
AU4685799 A
AU 4685799A
Authority
AU
Australia
Prior art keywords
telomerase inhibitors
telomerase
inhibitors
Prior art date
1998-06-17
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU46857/99A
Inventor
Federico C.A. Gaeta
Adam A. Galan
Erica A. Kraynack
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Geron Corp
Original Assignee
Geron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1998-06-17
Filing date
1999-06-15
Publication date
2000-01-05
1999-06-15
Application filed by Geron Corp
filed
Critical
Geron Corp
2000-01-05
Publication of AU4685799A
publication
Critical
patent/AU4685799A/en
Status
Abandoned
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
C07D209/04—Indoles; Hydrogenated indoles
C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/33—Heterocyclic compounds
A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
A61K31/404—Indoles, e.g. pindolol
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/33—Heterocyclic compounds
A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
A61K31/4965—Non-condensed pyrazines
A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
C07D209/04—Indoles; Hydrogenated indoles
C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
C07D209/04—Indoles; Hydrogenated indoles
C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
C07D209/32—Oxygen atoms
C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
AU46857/99A
1998-06-17
1999-06-15
Telomerase inhibitors
Abandoned
AU4685799A
(en)
Applications Claiming Priority (3)
Application Number
Priority Date
Filing Date
Title
US9906198A
1998-06-17
1998-06-17
US09099061
1998-06-17
PCT/US1999/013523
WO1999065875A1
(en)
1998-06-17
1999-06-15
Telomerase inhibitors
Publications (1)
Publication Number
Publication Date
AU4685799A
true
AU4685799A
(en)
2000-01-05
Family
ID=22272412
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU46857/99A
Abandoned
AU4685799A
(en)
1998-06-17
1999-06-15
Telomerase inhibitors
Country Status (2)
Country
Link
AU
(1)
AU4685799A
(en)
WO
(1)
WO1999065875A1
(en)
Families Citing this family (13)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
AU6062900A
(en)
1999-07-01
2001-01-22
Geron Corporation
Substituted indole compounds and their use for the treatment of cancer
FR2807659A1
(en)
*
2000-04-13
2001-10-19
Centre Nat Rech Scient
Pharmaceutical composition containing 5-hydroxy-oxindole or related material, useful for treating cancer, anxiety, hyperactivity, insomnia, depression or muscular pain
US7612065B2
(en)
2000-04-21
2009-11-03
Vertex Pharmaceuticals Incorporated
Inhibitors of c-JUN N-terminal kinases (JNK)
WO2001083450A2
(en)
2000-05-02
2001-11-08
Sugen, Inc.
(2-oxindol-3-ylidenyl)acetic acid derivatives and their use as protein kinase inhibitors
US7081470B2
(en)
2001-01-31
2006-07-25
H. Lundbeck A/S
Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
US20040127502A1
(en)
2001-01-31
2004-07-01
Synaptic Pharmaceutical Corporation
Use of GAL3 antagonist for treatment of depression
US7186745B2
(en)
2001-03-06
2007-03-06
Astrazeneca Ab
Indolone derivatives having vascular damaging activity
GB0111072D0
(en)
*
2001-05-04
2001-06-27
Pharmacia & Upjohn Spa
Disubstituted 7, 9-guaninium halides
US20030187026A1
(en)
2001-12-13
2003-10-02
Qun Li
Kinase inhibitors
US6797825B2
(en)
2001-12-13
2004-09-28
Abbott Laboratories
Protein kinase inhibitors
US7851468B2
(en)
2006-05-15
2010-12-14
Cephalon, Inc.
Substituted pyrazolo[3,4-d]pyrimidines
CN103159665B
(en)
*
2011-12-09
2017-01-25
天津市国际生物医药联合研究院
Isatin-5-amide inhibiting agent with inhibition effect against SARS coronavirus main protease
EP3604307A1
(en)
2012-01-26
2020-02-05
Angion Biomedica Corp.
Anti-fibrotic compounds and uses thereof
1999
1999-06-15
AU
AU46857/99A
patent/AU4685799A/en
not_active
Abandoned
1999-06-15
WO
PCT/US1999/013523
patent/WO1999065875A1/en
active
Application Filing
Also Published As
Publication number
Publication date
WO1999065875A1
(en)
1999-12-23
Similar Documents
Publication
Publication Date
Title
AU3485999A
(en)
1999-11-01
Neo-tryptophan
AU9392998A
(en)
1999-09-20
Pack-a-pillow
AU4685799A
(en)
2000-01-05
Telomerase inhibitors
AU3437799A
(en)
1999-11-08
City-car
AUPP328398A0
(en)
1998-05-21
Remove-a-line
AU3522399A
(en)
1999-11-01
Carvedilol-galenics
AU5407599A
(en)
2000-01-17
Sphingolipid-desaturase
AU3253699A
(en)
1999-09-06
Myxochelines
AU2445997A
(en)
1997-10-29
Telomerase inhibitors
AU8363398A
(en)
2000-01-24
Capotasto
AU2609599A
(en)
2000-07-12
Sensor-coupling
AU3204999A
(en)
1999-10-18
Futureball
AU2069199A
(en)
1999-08-09
Codelets
AU1055399A
(en)
1999-11-08
Rollerboard
AU2002400A
(en)
2000-08-01
Telomerase inhibitors
AU3347599A
(en)
1999-12-13
Aeromobile
AU5223199A
(en)
2000-02-14
Bathtub-bathseat
AU9347498A
(en)
2000-03-21
Imidazotriazolopyrimidines
AU3819799A
(en)
1999-11-23
Methoximinomethyloxathiazines
AU6079199A
(en)
2000-02-28
Sialyltransferase inhibitors
AU2440299A
(en)
1999-08-30
Telomerase inhibitors
AU2300499A
(en)
1999-08-30
Telomerase inhibitors
AU2840799A
(en)
1999-10-11
1-phosphanorbornadienes
AU8648998A
(en)
1999-03-08
Telomerase inhibitor
AU4768799A
(en)
2000-01-24
Bookcover
Legal Events
Date
Code
Title
Description
2001-03-08
MK6
Application lapsed section 142(2)(f)/reg. 8.3(3) – pct applic. not entering national phase
